TSHA Stock Surges on FDA Breakthrough Win for Game-Changing Rett Syndrome Treatment!
Folks, if you're glued to the markets this morning, you've probably spotted Taysha Gene Therapies (TSHA) lighting up the board like a fireworks show on the Fourth of July. As of this writing, shares are up a whopping 33%—that's right, rocketing from yesterday's...